Bart O. Williams
- Oncology top 0.2%
- Cancer-related Molecular Pathways 16
- Bone health and treatments 11
- Cancer Cells and Metastasis 10
- Molecular Biology top 0.2%
- Wnt/β-catenin signaling in development and cancer 75
- Cancer-related gene regulation 45
- Epigenetics and DNA Methylation 13
- Ubiquitin and proteasome pathways 9
- Cancer Research top 0.5%
- Cell Biology top 0.5%
- Aging top 2%
-
- Connective tissue disorders research 13
- Co-authors
- Tyler JacksRoderick T. BronsonLee Ann RemingtonRobert A. WeinbergEarlene M. SchmittShlomit HalachmiZhendong ZhongJ. Silvio Gutkind
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Bart O. Williams
146 papers receiving 15.3k citations
Hit Papers
Peers
Comparison fields: 5 of 140
- Oncology 5.6k
- Molecular Biology 11.2k
- Cancer Research 1.9k
- Cell Biology 1.5k
- Aging 152
Countries citing papers authored by Bart O. Williams
This map shows the geographic impact of Bart O. Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart O. Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart O. Williams more than expected).
Fields of papers citing papers by Bart O. Williams
This network shows the impact of papers produced by Bart O. Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart O. Williams. The network helps show where Bart O. Williams may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bart O. Williams, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2022 | 2 | |
| 3 | 2020 | 11 | |
| 4 | 2020 | 12 | |
| 5 | 2018 | 9 | |
| 6 | 2018 | 26 | |
| 7 | 2018 | 79 | |
| 8 | 2011 | 43 | |
| 9 | 2011 | 68 | |
| 10 | 2010 | 36 | |
| 11 | Mice deleted for the hyperparathyroidism-jaw tumour (HPT-JT) syndrome allele have abnormal parathyroids with increased proliferation rates | 2009 | 1 |
| 12 | 2008 | 79 | |
| 13 | 2008 | 156 | |
| 14 | 2008 | 54 | |
| 15 | 2008 | 22 | |
| 16 | 2007 | 78 | |
| 17 | 2007 | 135 | |
| 18 | Prostaglandin E 2 Promotes Colon Cancer Cell Growth Through a G s -Axin-ß-Catenin Signaling Axisbreakdown → | 2005 | 731 |
| 19 | 2004 | 74 | |
| 20 | 2002 | 20 |
About Bart O. Williams
Bart O. Williams is a scholar working on Molecular Biology, Oncology, Genetics, Immunology and Allergy and Cancer Research, having authored 148 papers that have together received 15.5k indexed citations. Recurring topics across this work include Wnt/β-catenin signaling in development and cancer (75 papers), Cancer-related gene regulation (45 papers), Cancer-related Molecular Pathways (16 papers), Connective tissue disorders research (13 papers), Epigenetics and DNA Methylation (13 papers), Bone health and treatments (11 papers), Cancer Cells and Metastasis (10 papers) and Ubiquitin and proteasome pathways (9 papers). The work is most often cited by research in Oncology (5.6k citations), Molecular Biology (11.2k citations), Cancer Research (1.9k citations), Cell Biology (1.5k citations) and Aging (152 citations). Bart O. Williams has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Tyler Jacks, Roderick T. Bronson, Lee Ann Remington, Robert A. Weinberg, Earlene M. Schmitt, Shlomit Halachmi, Zhendong Zhong, J. Silvio Gutkind, Sheri L. Holmen and Cassandra R. Zylstra. Their work appears in journals such as PLoS ONE, Bone Research, Bone, Journal of Biological Chemistry and Journal of Bone and Mineral Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.